Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sanfetrinem Cilexetil EBA in Pulmonary TB
NCT05388448Phase 2Completed
- Sponsor
- TASK Foundation
- Start
- Apr 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sanfetrinem cilexetil in pulmonary tuberculosis (TB), sponsored by TASK Foundation. Started Apr 2022; status: completed.
02
Drugs
Sanfetrinem cilexetil
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05388448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05388448.